Phillip R. Smith PhD

Director, Process Technology, GlaxoSmithKline

Phillip Smith is the Director of Process Technology in the GSK Biopharm R&D Clinical Manufacturing Pilot Plant in King of Prussia, PA. He leads a team of Scientists who conduct technology transfer, facility fit, scale-up, and troubleshooting activities for drug substance manufacturing processes. Other responsibilities include authoring of regulatory submissions and industrialization of new processing technologies. Previous roles include late-phase process development, characterization, and control strategy development for downstream unit operations in GSK Biopharm R&D, and early-phase downstream process development and technology transfer at Bristol-Myers Squibb. Phil is also a leader in Quality by Design practice within GSK and a member of the Biopharm Sustainability Team. He regularly presents at industry conferences and participates in various industry consortia. Phil received B.S. and M.S. degrees in Chemical Engineering from Brigham Young University, and a PhD degree in Chemical Engineering from Stanford University.